IDEXX LABORATORIES INC /DE Research and Development Expense
IDEXX LABORATORIES INC /DE (IDXX) reported Research and Development Expense of $65.43 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-04
- IDEXX LABORATORIES INC /DE research and development expense for the quarter ending 2026-06-30 was $65.43M, a 5.70% increase year-over-year.
- IDEXX LABORATORIES INC /DE research and development expense for the quarter ending 2026-03-31 was $65.79M, a 11.39% increase year-over-year.
- IDEXX LABORATORIES INC /DE research and development expense for the quarter ending 2025-12-31 was $66.83M, a 15.77% increase year-over-year.
- IDEXX LABORATORIES INC /DE research and development expense for the quarter ending 2025-09-30 was $63.41M, a 17.48% increase year-over-year.
- IDEXX LABORATORIES INC /DE research and development expense for fiscal 2025 was $251.21M, a 14.29% increase from fiscal 2024.
- IDEXX LABORATORIES INC /DE research and development expense for fiscal 2024 was $219.79M, a 15.10% increase from fiscal 2023.
- IDEXX LABORATORIES INC /DE research and development expense for fiscal 2023 was $190.95M, a 25.06% decline from fiscal 2022.
- IDEXX LABORATORIES INC /DE research and development expense for fiscal 2022 was $254.82M, a 58.26% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $65.43M 10-Q · filed 2026-08-04 | $131.22M 10-Q · filed 2026-08-04 | $198.05M derived: sum of 3 quarters · filed 2026-08-04 | $261.46M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $65.79M 10-Q · filed 2026-05-05 | $132.62M derived: sum of 2 quarters · filed 2026-05-05 | $196.04M derived: sum of 3 quarters · filed 2026-05-05 | $257.93M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $66.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $130.25M derived: sum of 2 quarters · filed 2026-02-20 | $192.15M derived: sum of 3 quarters · filed 2026-08-04 | $251.21M 10-K · filed 2026-02-20 |
| 2025-09-30 | $63.41M 10-Q · filed 2025-11-03 | $125.31M derived: sum of 2 quarters · filed 2026-08-04 | $184.37M 10-Q · filed 2025-11-03 | $242.10M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $61.90M 10-Q · filed 2026-08-04 | $120.96M 10-Q · filed 2026-08-04 | $178.69M derived: sum of 3 quarters · filed 2026-08-04 | $232.67M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $59.06M 10-Q · filed 2026-05-05 | $116.79M derived: sum of 2 quarters · filed 2026-05-05 | $170.77M derived: sum of 3 quarters · filed 2026-05-05 | $226.22M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $57.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $111.71M derived: sum of 2 quarters · filed 2026-02-20 | $167.16M derived: sum of 3 quarters · filed 2026-02-20 | $219.79M 10-K · filed 2026-02-20 |
| 2024-09-30 | $53.98M 10-Q · filed 2025-11-03 | $109.43M derived: sum of 2 quarters · filed 2025-11-03 | $162.06M 10-Q · filed 2025-11-03 | $213.88M derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-06-30 | $55.45M 10-Q · filed 2025-08-04 | $108.08M 10-Q · filed 2025-08-04 | $159.90M derived: sum of 3 quarters · filed 2026-02-20 | $207.86M derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-03-31 | $52.63M 10-Q · filed 2025-05-01 | $104.45M derived: sum of 2 quarters · filed 2026-02-20 | $152.41M derived: sum of 3 quarters · filed 2026-02-20 | $198.92M derived: sum of 4 quarters · filed 2026-02-20 |
| 2023-12-31 | $51.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $99.78M derived: sum of 2 quarters · filed 2026-02-20 | $146.28M derived: sum of 3 quarters · filed 2026-02-20 | $190.95M 10-K · filed 2026-02-20 |
| 2023-09-30 | $47.97M 10-Q · filed 2024-10-31 | $94.47M derived: sum of 2 quarters · filed 2024-10-31 | $139.14M 10-Q · filed 2024-10-31 | $182.56M derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-06-30 | $46.51M 10-Q · filed 2024-08-06 | $91.17M 10-Q · filed 2024-08-06 | $134.59M derived: sum of 3 quarters · filed 2025-02-21 | $182.60M derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-03-31 | $44.67M 10-Q · filed 2024-05-01 | $88.08M derived: sum of 2 quarters · filed 2025-02-21 | $136.10M derived: sum of 3 quarters · filed 2025-02-21 | $259.32M derived: sum of 4 quarters · filed 2025-02-21 |
| 2022-12-31 | $43.42M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $91.43M derived: sum of 2 quarters · filed 2025-02-21 | $214.65M derived: sum of 3 quarters · filed 2025-02-21 | $254.82M 10-K · filed 2025-02-21 |
| 2022-09-30 | $48.01M 10-Q · filed 2023-11-01 | $171.23M derived: sum of 2 quarters · filed 2023-11-01 | $211.40M 10-Q · filed 2023-11-01 | $256.71M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $123.22M 10-Q · filed 2023-08-01 | $163.39M 10-Q · filed 2023-08-01 | $208.69M derived: sum of 3 quarters · filed 2024-02-22 | $249.12M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $40.17M 10-Q · filed 2023-05-02 | $85.47M derived: sum of 2 quarters · filed 2024-02-22 | $125.90M derived: sum of 3 quarters · filed 2024-02-22 | $163.60M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $45.31M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $85.73M derived: sum of 2 quarters · filed 2024-02-22 | $123.43M derived: sum of 3 quarters · filed 2024-02-22 | $161.01M 10-K · filed 2024-02-22 |
| 2021-09-30 | $40.43M 10-Q · filed 2022-11-01 | $78.12M derived: sum of 2 quarters · filed 2022-11-01 | $115.70M 10-Q · filed 2022-11-01 | $154.48M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $37.70M 10-Q · filed 2022-08-02 | $75.28M 10-Q · filed 2022-08-02 | $114.05M derived: sum of 3 quarters · filed 2023-02-16 | $151.57M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $37.58M 10-Q · filed 2022-05-04 | $76.36M derived: sum of 2 quarters · filed 2023-02-16 | $113.87M derived: sum of 3 quarters · filed 2023-02-16 | $145.52M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $38.78M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $76.29M derived: sum of 2 quarters · filed 2023-02-16 | $107.94M derived: sum of 3 quarters · filed 2023-02-16 | $141.25M 10-K · filed 2023-02-16 |
| 2020-09-30 | $37.52M 10-Q · filed 2021-11-02 | $69.16M derived: sum of 2 quarters · filed 2021-11-02 | $102.47M 10-Q · filed 2021-11-02 | $137.63M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | $31.64M 10-Q · filed 2021-07-30 | $64.95M 10-Q · filed 2021-07-30 | $100.11M derived: sum of 3 quarters · filed 2022-02-16 | $134.38M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | $33.31M 10-Q · filed 2021-05-04 | $68.47M derived: sum of 2 quarters · filed 2022-02-16 | $102.73M derived: sum of 3 quarters · filed 2022-02-16 | $134.99M derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | $35.16M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $69.42M derived: sum of 2 quarters · filed 2022-02-16 | $101.68M derived: sum of 3 quarters · filed 2022-02-16 | $133.19M 10-K · filed 2022-02-16 |
| 2019-09-30 | $34.26M 10-Q · filed 2020-10-29 | $66.52M derived: sum of 2 quarters · filed 2020-10-29 | $98.03M 10-Q · filed 2020-10-29 | $128.17M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-06-30 | $32.26M 10-Q · filed 2020-07-31 | $63.77M 10-Q · filed 2020-07-31 | $93.91M derived: sum of 3 quarters · filed 2021-02-12 | $123.10M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-03-31 | $31.51M 10-Q · filed 2020-04-30 | $61.65M derived: sum of 2 quarters · filed 2021-02-12 | $90.84M derived: sum of 3 quarters · filed 2021-02-12 | $120.35M derived: sum of 4 quarters · filed 2021-02-12 |
| 2018-12-31 | $30.14M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $59.33M derived: sum of 2 quarters · filed 2021-02-12 | $88.84M derived: sum of 3 quarters · filed 2021-02-12 | $117.86M 10-K · filed 2021-02-12 |
| 2018-09-30 | $29.19M 10-Q · filed 2019-10-31 | $58.70M derived: sum of 2 quarters · filed 2019-10-31 | $87.72M 10-Q · filed 2019-10-31 | $116.53M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-06-30 | $29.51M 10-Q · filed 2019-08-01 | $58.53M 10-Q · filed 2019-08-01 | $87.34M derived: sum of 3 quarters · filed 2020-02-14 | $114.93M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-03-31 | $29.02M 10-Q · filed 2019-05-01 | $57.83M derived: sum of 2 quarters · filed 2020-02-14 | $85.42M derived: sum of 3 quarters · filed 2020-02-14 | $112.42M derived: sum of 4 quarters · filed 2020-02-14 |
| 2017-12-31 | $28.81M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | $56.39M derived: sum of 2 quarters · filed 2020-02-14 | $83.39M derived: sum of 3 quarters · filed 2020-02-14 | $109.18M 10-K · filed 2020-02-14 |
| 2017-09-30 | $27.59M 10-Q · filed 2018-11-01 | $54.58M derived: sum of 2 quarters · filed 2018-11-01 | $80.37M 10-Q · filed 2018-11-01 | $105.79M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-06-30 | $27.00M 10-Q · filed 2018-08-01 | $52.79M 10-Q · filed 2018-08-01 | $78.21M derived: sum of 3 quarters · filed 2019-02-15 | $103.88M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-03-31 | $25.79M 10-Q · filed 2018-05-04 | $51.21M derived: sum of 2 quarters · filed 2019-02-15 | $76.88M derived: sum of 3 quarters · filed 2019-02-15 | $102.29M derived: sum of 4 quarters · filed 2019-02-15 |
| 2016-12-31 | $25.42M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $51.09M derived: sum of 2 quarters · filed 2019-02-15 | $76.50M derived: sum of 3 quarters · filed 2019-02-15 | $101.12M 10-K · filed 2019-02-15 |
| 2016-09-30 | $25.67M 10-Q · filed 2017-10-31 | $51.08M derived: sum of 2 quarters · filed 2017-10-31 | $75.70M 10-Q · filed 2017-10-31 | $101.20M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-06-30 | $25.41M 10-Q · filed 2017-08-01 | $50.03M 10-Q · filed 2017-08-01 | $75.53M derived: sum of 3 quarters · filed 2018-02-16 | $100.39M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-03-31 | $24.62M 10-Q · filed 2017-04-28 | $50.12M derived: sum of 2 quarters · filed 2018-02-16 | $74.98M derived: sum of 3 quarters · filed 2018-02-16 | $99.30M derived: sum of 4 quarters · filed 2018-02-16 |
| 2015-12-31 | $25.50M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $50.36M derived: sum of 2 quarters · filed 2018-02-16 | $74.67M derived: sum of 3 quarters · filed 2018-02-16 | $99.68M 10-K · filed 2018-02-16 |
| 2015-09-30 | $24.86M 10-Q · filed 2016-11-01 | $49.18M derived: sum of 2 quarters · filed 2016-11-01 | $74.19M 10-Q · filed 2016-11-01 | $99.05M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | $24.32M 10-Q · filed 2016-08-02 | $49.32M 10-Q · filed 2016-08-02 | $74.19M derived: sum of 3 quarters · filed 2017-02-17 | $99.04M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | $25.01M 10-Q · filed 2016-04-29 | $49.88M derived: sum of 2 quarters · filed 2017-02-17 | $74.72M derived: sum of 3 quarters · filed 2017-02-17 | $100.16M derived: sum of 4 quarters · filed 2017-02-17 |
| 2014-12-31 | $24.87M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $49.72M derived: sum of 2 quarters · filed 2017-02-17 | $75.15M derived: sum of 3 quarters · filed 2017-02-17 | $98.26M 10-K · filed 2017-02-17 |
| 2014-09-30 | $24.85M 10-Q · filed 2015-10-28 | $50.28M derived: sum of 2 quarters · filed 2015-10-28 | $73.39M 10-Q · filed 2015-10-28 | $95.89M derived: sum of 4 quarters · filed 2016-02-17 |
| 2014-06-30 | $25.43M 10-Q · filed 2015-07-30 | $48.55M 10-Q · filed 2015-07-30 | $71.04M derived: sum of 3 quarters · filed 2016-02-17 | $92.61M derived: sum of 4 quarters · filed 2016-02-17 |
| 2014-03-31 | $23.11M 10-Q · filed 2015-04-28 | $45.61M derived: sum of 2 quarters · filed 2016-02-17 | $67.18M derived: sum of 3 quarters · filed 2016-02-17 | $89.36M derived: sum of 4 quarters · filed 2016-02-17 |
| 2013-12-31 | $22.50M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-17 | $44.06M derived: sum of 2 quarters · filed 2016-02-17 | $66.25M derived: sum of 3 quarters · filed 2016-02-17 | $88.00M 10-K · filed 2016-02-17 |
| 2013-09-30 | $21.57M 10-Q · filed 2014-10-24 | $43.75M derived: sum of 2 quarters · filed 2014-10-24 | $65.51M 10-Q · filed 2014-10-24 | $86.56M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-06-30 | $22.18M 10-Q · filed 2014-07-25 | $43.94M 10-Q · filed 2014-07-25 | $64.99M derived: sum of 3 quarters · filed 2015-02-17 | $85.34M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-03-31 | $21.76M 10-Q · filed 2014-04-25 | $42.81M derived: sum of 2 quarters · filed 2015-02-17 | $63.16M derived: sum of 3 quarters · filed 2015-02-17 | $83.22M derived: sum of 4 quarters · filed 2015-02-17 |
| 2012-12-31 | $21.05M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $41.40M derived: sum of 2 quarters · filed 2015-02-17 | $61.46M derived: sum of 3 quarters · filed 2015-02-17 | $82.01M 10-K · filed 2015-02-17 |
| 2012-09-30 | $20.35M 10-Q · filed 2013-10-22 | $40.41M derived: sum of 2 quarters · filed 2013-10-22 | $60.96M 10-Q · filed 2013-10-22 | $81.17M derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-06-30 | $20.06M 10-Q · filed 2013-07-23 | $40.62M 10-Q · filed 2013-07-23 | $60.82M derived: sum of 3 quarters · filed 2014-02-18 | $80.22M derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-03-31 | $20.56M 10-Q · filed 2013-04-23 | $40.76M derived: sum of 2 quarters · filed 2014-02-18 | $60.17M derived: sum of 3 quarters · filed 2014-02-18 | $78.79M derived: sum of 4 quarters · filed 2014-02-18 |
| 2011-12-31 | $20.20M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18 | $39.61M derived: sum of 2 quarters · filed 2014-02-18 | $58.23M derived: sum of 3 quarters · filed 2014-02-18 | $76.04M 10-K · filed 2014-02-18 |
| 2011-09-30 | $19.41M 10-Q · filed 2012-10-19 | $38.03M derived: sum of 2 quarters · filed 2012-10-19 | $55.84M 10-Q · filed 2012-10-19 | $73.32M derived: sum of 4 quarters · filed 2013-02-19 |
| 2011-06-30 | $18.62M 10-Q · filed 2012-07-20 | $36.43M 10-Q · filed 2012-07-20 | $53.91M derived: sum of 3 quarters · filed 2013-02-19 | $71.11M derived: sum of 4 quarters · filed 2013-02-19 |
| 2011-03-31 | $17.81M 10-Q · filed 2012-04-20 | $35.29M derived: sum of 2 quarters · filed 2013-02-19 | $52.49M derived: sum of 3 quarters · filed 2013-02-19 | $69.70M derived: sum of 4 quarters · filed 2013-02-19 |
| 2010-12-31 | $17.48M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19 | $34.68M derived: sum of 2 quarters · filed 2013-02-19 | $51.89M derived: sum of 3 quarters · filed 2013-02-19 | $68.60M 10-K · filed 2013-02-19 |
| 2010-09-30 | $17.20M 10-Q · filed 2011-10-21 | $34.41M derived: sum of 2 quarters · filed 2011-10-21 | $51.12M 10-Q · filed 2011-10-21 | $67.13M derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-06-30 | $17.21M 10-Q · filed 2011-07-22 | $33.91M 10-Q · filed 2011-07-22 | $49.92M derived: sum of 3 quarters · filed 2012-02-17 | $66.51M derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-03-31 | $16.71M 10-Q · filed 2011-04-21 | $32.72M derived: sum of 2 quarters · filed 2012-02-17 | $49.30M derived: sum of 3 quarters · filed 2012-02-17 | $65.89M derived: sum of 4 quarters · filed 2012-02-17 |
| 2009-12-31 | $16.01M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | $32.59M derived: sum of 2 quarters · filed 2012-02-17 | $49.19M derived: sum of 3 quarters · filed 2012-02-17 | $65.12M 10-K · filed 2012-02-17 |
| 2009-09-30 | $16.58M 10-Q · filed 2010-10-22 | $33.18M derived: sum of 2 quarters · filed 2010-10-22 | $49.12M 10-Q · filed 2010-10-22 | |
| 2009-06-30 | $16.59M 10-Q · filed 2010-07-23 | $32.53M 10-Q · filed 2010-07-23 | ||
| 2008-12-31 | $70.67M 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |